Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Notes on the therapy of multiple sclerosis (MS)

A R Massaro1

  • 1Istituto di Neurologia, Università Cattolica Sacro Cuore, Roma.

Italian Journal of Neurological Sciences
|December 1, 1992
PubMed
Summary

This review discusses the dual treatment strategy for multiple sclerosis (MS), focusing on managing acute phases and blocking underlying disease mechanisms. Advances in MRI, neuroimmunology, and neurobiology inform current therapeutic approaches for MS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The neural cell adhesion molecule (NCAM) present in the cerebrospinal fluid of multiple sclerosis patients is unsialylated.

European review for medical and pharmacological sciences·2009
Same author

Transcranial Doppler ultrasonography in adults with sickle cell disease.

Neurology·2006
Same author

Migraine-mimicking headache and sickle cell disease: a transcranial Doppler study.

Cephalalgia : an international journal of headache·2006
Same author

Transcranial Doppler assessment of cerebral blood flow: effect of cardiac transplantation.

Neurology·2006
Same author

Reactive astrocytes within the acute plaques of multiple sclerosis are PSA-NCAM positive.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2003
Same author

The role of NCAM in remyelination.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2002

Area of Science:

  • Neuroimmunology
  • Neurobiology
  • Radiology (Magnetic Resonance Imaging - MRI)

Background:

  • Multiple Sclerosis (MS) treatment is guided by insights from neuroimmunology, neurobiology, and MRI.
  • The etiology of MS remains unknown, necessitating a dual therapeutic strategy.
  • Current treatments address acute disease phases and underlying pathogenetic mechanisms.

Purpose of the Study:

  • To review and discuss the latest advancements in multiple sclerosis therapeutics.
  • To provide insights based on clinical and laboratory experience regarding MS treatment rationale.
  • To highlight the contributions of MRI, neuroimmunology, and neurobiology to MS therapy.

Main Methods:

  • Literature review and synthesis of current research in neuroimmunology, neurobiology, and MRI applications in MS.
  • Discussion of established and emerging therapeutic strategies for multiple sclerosis.
  • Analysis of clinical and laboratory data to support therapeutic rationale.

Main Results:

  • MRI, neuroimmunology, and neurobiology have significantly advanced the understanding of MS pathogenesis.
  • A dual treatment policy is employed: managing acute relapses and targeting chronic disease progression.
  • The review synthesizes recent findings to inform therapeutic decision-making in MS.

Conclusions:

  • Understanding the pathogenetic mechanisms of MS is crucial for effective treatment.
  • Therapeutic approaches for MS are evolving, integrating neurobiological and immunological insights.
  • Continued research in neuroimaging and neuroimmunology is essential for improving MS management.

Related Experiment Videos